MyFinsight
Home
Blog
About
Contact
rgbp: the income statement
Download
Download image
Net loss
-$1,274.502K
(-90.72%↓ Y/Y)
Net loss before
income taxes
-$1,274.502K
(-90.72%↓ Y/Y)
Related Party
$110.001K
(0.00%↑ Y/Y)
Nonrelated Party
$126.56K
(0.00%↑ Y/Y)
Total other income
(expense), net
-$935.962K
(-272.84%↓ Y/Y)
Loss from operations
-$338.54K
(18.86%↑ Y/Y)
Net revenue
$236.561K
(0.00%↑ Y/Y)
Penalties
$50K
Derivative income
(expense)
-$675.528K
(-16412.54%↓ Y/Y)
Interest expense
attributable to amortization...
$52.148K
(79.83%↑ Y/Y)
Interest expense
$158.286K
(118.49%↑ Y/Y)
Total operating
expenses
$575.101K
(-12.03%↓ Y/Y)
Rent
$90K
(16.56%↑ Y/Y)
Consulting and
professional fees
$398.263K
(9.42%↑ Y/Y)
General and
administrative
$75.113K
(27.48%↑ Y/Y)
Research and development
$11.725K
(-92.37%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Regen BioPharma Inc (RGBP)
Regen BioPharma Inc (RGBP)